What is Targeted Therapy?
Targeted therapy is a type of medical treatment that uses drugs or other substances to precisely identify and attack specific types of cells, typically cancer cells, while causing minimal damage to normal cells. This approach is grounded in understanding the genetic and molecular basis of diseases, aiming to disrupt pathways critical for disease progression.
What Types of Diseases Can Be Treated with Targeted Therapy?
While targeted therapy is most commonly associated with cancer treatment, it is also being explored for other conditions, including autoimmune diseases, cardiovascular diseases, and infectious diseases. The success of targeted therapy in these areas depends on identifying specific molecular targets that are critical to the disease process.
What Are the Challenges in Developing Targeted Therapies?
Developing targeted therapies involves several challenges, including the identification of appropriate molecular targets, the potential for
drug resistance, and the high cost of development and production. Additionally, targeted therapies may not be effective for all patients, necessitating personalized approaches based on individual genetic and molecular profiles.
How Does Epidemiology Play a Role in Targeted Therapy?
Epidemiology contributes to targeted therapy by identifying patterns and determinants of diseases in populations. Through
epidemiological studies, researchers can identify potential molecular targets and risk factors, enabling the development of therapies that are tailored to specific populations. Moreover, epidemiology helps in evaluating the effectiveness and safety of targeted therapies in real-world settings.